| Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin ... - PR Newswire (press release) |
|
|
PR Newswire (press release)Notably, in these trials in type 2 diabetes patients with mild and moderate renal impairment, linagliptin blood plasma levels were comparable to those seen ...Boehringer's First Diabetes Pill Lowered Blood Sugar in Study BusinessWeekBoehringer Ingelheim Announces Results of Phase III Data Showing That ... read more |